Ultragenyx Pharmaceutical has seen its stock slide over several years, even as the business secures new drug approvals and restructures to cut costs. This puts fresh focus on what investors are really...
Source LinkUltragenyx Pharmaceutical has seen its stock slide over several years, even as the business secures new drug approvals and restructures to cut costs. This puts fresh focus on what investors are really...
Source Link
Comments